Cryo-Cell International, Inc. balance sheet CCEL

Annual Quarterly

As of Aug 31, 2026, Cryo-Cell International, Inc. had total assets of $62.3 million and total liabilities of $78.7 million. Total assets were down 1.4% from a year earlier. Stockholders' equity was negative, at -$16.4 million, because liabilities exceed assets. It held $4.2 million in cash and investments against $8.8 million of total debt, net debt of $4.6 million. The current ratio, current assets divided by current liabilities, was 0.86.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Q3 FY2026
Aug 31, 2026
Q2 FY2026
May 31, 2026
Q1 FY2026
Feb 28, 2026
Q4 FY2025
Nov 30, 2025
Q3 FY2025
Aug 31, 2025
Q2 FY2025
May 31, 2025
Q1 FY2025
Feb 28, 2025
Q4 FY2024
Nov 30, 2024
Assets
Cash
1
+437.6%
1
+269.0%
0
+11.9%
0
-43.1%
0
+34.3%
0
-70.7%
0
-9.7%
1
+38.1%
Short-term investments
3
-5.2%
3
-38.2%
3
-18.6%
3
+1.4%
3
+53.2%
4
+304.9%
3
+344.6%
3
+411.2%
Cash and investments
4
+31.3%
3
-28.6%
3
-16.7%
3
-5.7%
3
+51.5%
4
+189.7%
3
+255.2%
3
+256.7%
Receivables
7
+0.0%
7
-0.3%
7
-5.5%
7
-6.3%
7
-0.6%
7
+1.5%
7
+7.2%
7
+11.1%
Inventory
1
-18.6%
0
-54.2%
0
-51.1%
0
-37.8%
1
-10.4%
1
-4.4%
1
-3.3%
1
-14.5%
Total current assets
13
+12.8%
11
-13.4%
11
-11.4%
12
-6.3%
12
+9.5%
13
+28.5%
13
+32.3%
13
+32.8%
Property and equipment, net
21
-3.1%
21
-3.4%
21
-3.9%
21
-3.9%
21
-4.2%
21
-3.5%
22
+0.6%
22
+4.3%
Goodwill
2
+0.0%
2
+0.0%
2
+0.0%
2
+0.0%
2
+0.0%
2
+0.0%
2
+0.0%
2
+0.0%
Total assets
62
-1.4%
61
-5.8%
61
-5.4%
62
-4.6%
63
+0.4%
64
+3.0%
64
+4.3%
65
+0.0%
Liabilities and equity
Accounts payable
2
-7.3%
3
+27.0%
3
+20.3%
3
+52.5%
3
+30.6%
2
+22.6%
3
-8.4%
2
-40.7%
Total current liabilities
15
-16.9%
16
-26.8%
18
-18.2%
20
-8.4%
18
+5.9%
22
+11.8%
22
+12.1%
22
+3.5%
Total liabilities
79
+0.9%
78
-1.9%
79
+0.3%
80
+3.1%
78
+7.6%
80
+9.1%
79
+9.7%
78
+7.8%
Stockholders' equity
-16
-10.5%
-18
-14.1%
-18
-25.5%
-19
-40.8%
-15
-55.2%
-16
-44.9%
-15
-41.8%
-13
-19.8%
Debt
Long-term debt
8
-1.7%
8
-1.7%
8
-1.6%
8
-1.5%
8
-1.4%
8
-1.3%
8
-1.3%
8
-1.3%
Lease liabilities
1
-43.0%
1
-6.5%
1
-5.2%
1
-3.1%
1
+0.9%
1
-24.5%
1
-18.0%
1
-13.4%
Total debt
9
-6.2%
9
-2.0%
9
-1.9%
9
-1.6%
9
-1.2%
9
-3.7%
9
-3.1%
9
-2.7%
Net cash
-5
+25.7%
-6
-22.9%
-6
-6.9%
-6
-0.8%
-6
+16.3%
-5
+40.8%
-6
+32.5%
-6
+31.9%
Ratios
Current ratio
0.86x
0.71x
0.62x
0.59x
0.63x
0.60x
0.58x
0.58x
Debt to EBITDA
7.60x
10.28x
7.77x
6.31x
1.77x
1.90x
2.03x
2.26x
Return on assets
-3.12%
-4.06%
-4.38%
-3.94%
-0.75%
-0.27%
0.20%
0.62%
Book value per share
-2.03
-2.20
-2.28
-2.31
-1.84
-1.93
-1.81
-1.64
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
CCEL (NYSE)
Fiscal year ends
November 30
Incorporated in
DE
Headquarters
Oldsmar, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
862692
Former names
CRYO CELL INTERNATIONAL INC (until Oct 28, 2026)

Other Services-Misc Health & Allied Services, NEC companies

All 15 Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.